Idexx Laboratories Product revenue — Cost of revenue decreased by 10.4% to $194.43M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.8%, from $175.53M to $194.43M. Over 4 years (FY 2021 to FY 2025), Product revenue — Cost of revenue shows an upward trend with a 5.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A decrease relative to product revenue suggests improved manufacturing efficiency or favorable economies of scale. An increase may signal rising input costs, supply chain inefficiencies, or changes in the product mix toward lower-margin items.
This metric captures the direct costs associated with manufacturing and delivering the physical diagnostic products sold...
Comparable to cost of goods sold (COGS) for physical products in the life sciences and medical device sectors, where manufacturing scale is a key driver of profitability.
idxx_segment_product_revenue_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $169.83M | $166.75M | $172.97M | $162.07M | $167.32M | $158.55M | $168.56M | $173.61M | $180.00M | $178.53M | $185.82M | $176.77M | $180.64M | $176.27M | $182.40M | $175.53M | $205.15M | $206.96M | $216.98M | $194.43M |
| QoQ Change | — | -1.8% | +3.7% | -6.3% | +3.2% | -5.2% | +6.3% | +3.0% | +3.7% | -0.8% | +4.1% | -4.9% | +2.2% | -2.4% | +3.5% | -3.8% | +16.9% | +0.9% | +4.8% | -10.4% |
| YoY Change | — | — | — | — | -1.5% | -4.9% | -2.5% | +7.1% | +7.6% | +12.6% | +10.2% | +1.8% | +0.4% | -1.3% | -1.8% | -0.7% | +13.6% | +17.4% | +19.0% | +10.8% |